The aim of this study was to evaluate the changes of the regulatory T cell subset in peripheral blood caused by gestational age and premature rupture of membranes (PROM) with or without labor to verify the role of regulatory T cells in pregnancy. Patients and Methods: We investigated regulatory T cell distribution in the peripheral blood of pregnancies during the first trimester (group I, n = 2), the second trimester (group II, n = 12), and the third trimester without PROM and labor (group III, n = 15). In addition, we evaluated pregnancies in the third trimester complicated by PROM (group IV, n = 4) and labor with no complication by PROM (Group V, n = 5). Comparisons were made with non-pregnant controls (group VI, n = 4) using flow cytometry. Results: During uncomplicated pregnancy, the CD4 + CD25 bright regulatory T cell population decreased with advancing gestational age (group I = 3.35 ± 0.47, group II = 2.91 ± 1.44, group III = 2.81 ± 1.36, group VI = 2.52 ± 0.71, p = NS). When we compared group IV with group III and V to evaluate the changes of the regulatory T cells with PROM, the CD4 + CD25 bright regulatory T cell population was significantly decreased in group IV compared to group III (p= 0.001) and group V (p = 0.026).
INTRODUCTION
Traditionally, the fetus has been viewed as a semi-allograft. However, pregnant women do not experience fatal rejection. This has been explained by the concept that pregnancy is an immunosuppressive state even though pregnant women are not susceptible to overwhelming infection. It, however, remains unknown how the maternal immune system copes with the fetus without activating rejection. Recently, regulatory T cells have been suggested to be important players in the immune tolerance of the fetus during pregnancy. 1, 2 These regulatory T cells are present at the fetal-maternal interface and have been reported to be important for the maternal acceptance of the allogenic fetus. 1 The population of decidual CD4 + CD25 bright regulatory T cells was found to be decreased with spontaneous abortions compared to normal pregnancies, suggesting that decidual CD4 + CD25 bright regulatory T cells contribute to the mechanisms that mediate maternal immune tolerance during pregnancy. 3 Regulatory T cells have also been found in the peripheral blood lymphocytes of pregnant women. 4, 5 Like many other obstetrical problems, the etiology of PROM is multifactorial. However, a subclinical intrauterine infection has been implicated as a major factor contributing to the pathogenesis of PROM. 6 Most subclinical infections are believed to have ascended from the lower genital tract. The pathogens are thought to ascend into the decidua and enter the fetal membranes, where they generate a cascade of maternal and fetal inflammatory responses that culminate in 
PATIENTS AND METHODS
We collected blood from women visiting Korea University Medical Center from September 2005 to August 2006. Inclusion criteria were healthy non-pregnant women of reproductive age and women in the first, second, and third trimesters of a normal singleton pregnancy. Patients with medical problems such as hypertensive disorder, diabetes mellitus, or autoimmune diseases were excluded. Blood samples were obtained from women in the first trimester during routine prenatal laboratory testing at 7 -9 weeks gestation and from women in the routine second trimester screening for gestational diabetes at 25 -27 weeks gestation. Third trimester samples were obtained from women without labor or PROM who were admitted for elective cesarean section as well as from women with labor or PROM at 37 -40 weeks gestation. Non-pregnant controls were healthy volunteers of reproductive age. The institutional review board approved this study and informed consent was obtained from all patients.
The diagnosis of PROM was confirmed by the clinical findings of a posterior vaginal pool and the vaginal PH or ferning. Labor was defined as painful regular uterine contractions with cervical effacement. There were 32 patients enrolled in the present stud, and they were divided into the following 6 groups: (1) group I, 2 women in the first trimester of pregnancy; (2) group II, 12 women in the second trimester of pregnancy; (3) group III, 15 women in the third trimester of pregnancy without labor or PROM; (4) group IV, 4 women in the third trimester complicated with PROM; (5) group V, 5 women in the third trimester with labor; and (6) group VI, 4 women who were non-pregnant controls.
Fresh blood samples were collected in ethylenediaminetetraacetic acid (EDTA) tubes and analyzed within 24 h. Regulatory T cells were assayed by flow cytometry using CD4-FITC, CD25-PC5.5, CD152-PE (Beckman Coulter, CA, USA) or Foxp3-FITC (eBioscience, CA, USA) monoclonal antibodies. Then, 100 L of blood were incubated μ with 10 L of antibodies for 15 min at room μ temperature in the dark. After incubation, the cells were lysed by Optylase (RBC lysis buffer, Beckman Coulter), washed, and measured. Data acquisition was performed using Cytomics FC500 (Beckman Coulter).
All data are expressed as median and interquartile ranges. Statistical analysis was performed using the Mann-Whitney U test. A p < 0.05 was considered statistically significant.
RESULTS
In all lymphocyte isolates derived from blood, CD4 + CD25 bright regulatory T cells could be identified (Fig. 1) . We analyzed the levels of CD4 + CD25 bright regulatory T cells in each of the study groups. bright regulatory T cells in women with uncomplicated pregnancies (groups I, II, and III) to the non-pregnant controls (group IV). During the first trimester, the regulatory T cell population was the highest followed by the second trimester, third trimester, and the nonpregnant controls, but the differences were not statistically significant (Fig. 2) . Second, to investigate the changes of the CD4 + CD25 bright regulatory T cells during the third trimester in pregnancies with PROM, we compared group IV to group III and V, and found that the regulatory T cells were significantly decreased in group IV compared to group III (p < 0.001) and group V (p = 0.026). Fig. 3 shows that the percentage of CD4 + CD25 bright regulatory T cells decreased in pregnancies with PROM. Finally, there was no significant difference identified (Fig. 4) in the distribution of the regulatory T cells between the third trimester in pregnancies with or without labor (groups III and V).
DISCUSSION
In this study, we demonstrated the differences in CD4 Group I, the first trimester of pregnancy; Group II, the second trimester of pregnancy; Group III, the third trimester of pregnancy without labor or PROM; Group IV, the third trimester complicated with PROM; Group V, the third trimester with labor; Group VI, non-pregnant controls. Data are median and interquartile ranges. However, the etiology of PROM is multifactorial. The present case-control study had a relatively small sample size and did not include pregnancies with preterm premature rupture of membranes. Therefore, the results should be interpreted with caution.
There are 2 arms of the immune system, the innate and the adaptive system, both of which have cellular and humoral components.
14 During pregnancy, the maternal innate immune system is stimulated, 15, 16 bright regulatory T cells increased in the blood samples from pregnant women compared to non-pregnant controls, and were the highest in the first trimester followed by the second and third trimesters although these differences were not statistically significant. In addition, CD4 + CD25 + regulatory T cells have been reported to decrease in the maternal peripheral blood during the third trimester of pregnancy compared to the first and second trimester, however, with no differences detected between CD4 + CD25 dim and CD4 + CD25 bright regulatory T 
A B
cells. 4, 18 In this study, we calculated the per- These findings might be due to activation of the innate immune system, which is an integral part of the immune response during labor, rather than the adaptive immune system regardless of regulatory T cells.
In conclusion, the increase in regulatory T cells during early pregnancy might be related to maternal tolerance during implantation period of the fetus. We identified for the first time the possibility that a decreased number of regulatory T cells might be one of the causes of PROM during the third trimester. Further study is needed to determine the relationship between PROM and regulatory T cells in a larger population of women under different conditions. 
